Aptose Biosciences To Go Through With Public Offering, What This Could Do for the Stock

On July 16th, Aptose or NASDAQ: APTO announced that they will have a public offering of 10.5 million shares at $5.25 per on July 20th.

What does this mean?

Basically, a company will sell shares of their own stock to raise capital in a public offering. This is usually something small-caps go through with if they are not making money or need more capital for operations. In APTO's case, they are running out of cash, and this isn't the first time they've done a public offering. Seeking Alpha mentions that approximately $55 million to be raised in the offering.

What is Aptose Biosciences?

ATPO is a clinical-stage biotech that works in the field of oncology, or treating tumors. Looking at the past 4 years, they have not made a profit like most biotechs because of the amount of spending each company has to undertake in their clinical-trial stages.

https://finance.yahoo.com/quote/APTO/cash-flow?p=APTO

Their cash flow looks like the source of their problems. Financing cash flow left at $436,000 in March with all other areas negative except end cash position. The fact that the company is undergoing another public offer must mean that they still haven't gathered enough cash or need a lot more. $55 million should help pad expenses for their CG-806 and APTO-253 clinical trials next quarter or maybe further down the road.

What I think

Since the offering is at $5.25 per share, it's expected to see the price drop. However, there is something I looked at that could be a good sign for Aptose.

https://www.marketbeat.com/stocks/NASDAQ/APTO/institutional-ownership/

Almost 40% of the stock is owned by institutions, and Q2 saw a lot of increases of institutional stakes betting on this company. A good thing about institutional ownership is that it can limit price volatility since it's unlikely smart money will decide to buy up shares and dump it all the next quarter. $22 million bought by institutions also shows investor interest which could mean APTO is getting close to a clinical breakthrough. But that is pure speculation that I made so take that with a grain of salt.

Technicals

The stock looks like it's just about oversold on the 14-Day RSI chart, and price dips under the 200 Day Moving Average after trading above it since November of last year. Patterns on the RSI show that the stock could be gearing for another swing to the upside. If APTO's RSI slides under 30, it could be something to consider buying. On Marketbeat, analysts give this stock a buy rating with an $11.40 Price Target the past two quarters.

https://www.marketbeat.com/stocks/NASDAQ/APTO/price-target/

Featured Pic: https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/5491524/5491524-1589481251193-a23bd02f95f7c.jpg


Thanks for reading! If you are interested in joining our trading community, we have chat rooms, trade alerts from our top traders, and educational content. You can join using the link below, and get a discount on your membership.

Disclaimer:

Please note that this email is my personal opinion only. I am not a licensed financial advisor, and any information shared or discussed is not to be construed as investment advice. Trading and investing involves a degree of risk, and is not suitable to all investors. Please consult with your financial advisor before making any sort of investment decisions.

Latest Market Insights
September 21, 2020
Trade Setups on Falling Markets This Week

EUR/USD Bearish GBP/USD Bearish AUD/NZD Bearish XAU/USD Bullish SPX500 Bearish EU struggles to pass 1.2000s as US markets fall from overvalued prices in the stock market. The pair is back in a support zone showing that price wants to go lower. A break in that support zone (which is a common pattern we see in […]

Read More
September 20, 2020
Markets Make Lower Lows, Tesla Battery Day, What to Expect

Last week was rough for the market as the S&P and Nasdaq draw lower lows on the daily chart. The Dow Jones Industrial was the only index to look in the best shape as tech continues to fall under pressure. The main drivers for the market, which have been carrying pairs like GBPUSD and EURUSD, […]

Read More
September 19, 2020
Weekly Forex Forecast for USDCHF, GBPUSD, AUDNZD, XAUUSD (20-25 September 2020)

Weekly Forex Forecast for USDCHF, GBPUSD, AUDNZD, XAUUSD (20-25 September 2020) Hey everyone! Welcome to this weeks forex forecast for the week ending September 25th, 2020. I'm TraderBart with A1 Trading, and this week I'll be looking at USDCHF, GBPUSD, AUDNZD & XAUUSD. USD/CHF Zooming out, we can see price is travelling in a strong […]

Read More

Related Articles

August 28, 2020
Economic stimulus and the Role of Central Banks

Politics preventing new financial stimulus The economic recovery in the major global economic powers depends on several important factors. One of the most vital part, the spread of the virus and the government's answers to it. With a decrease in daily cases of COVID-19 to 50,000 in the U.S.A. Yet U.S. A remains the most […]

Read More
August 26, 2020
How to Spot a Scammer

Our team has received many reports of scammers using our content and pretending to be us. Unfortunately, these accounts are difficult to shut down as there are many that we do not know of. While we will continue to do our best to get these accounts shut down as we receive reports, we are unable to […]

Read More
August 22, 2020
Legends of Investing - The Story of Warren Buffet

Warren Buffett is one of the most idolised, investors in the world. At the time of writing , his company, Berkshire Hathaway, has a market cap of $495 billion and Buffett himself has a net worth of $79 billion. His approach to value investing, combined with his influence over the companies he invests in , […]

Read More

A1 Trading Company

A1 Trading Company is a financial services and media business founded in Atlanta, USA.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram